Study of the Utility and Impact of Plasma <i>p</i> ‐tau181 Alzheimer's Biomarkers ‐ SUIT‐ABLE: Clinical Care Outcomes
Plasma p-tau181 testing enhances clinician diagnostic confidence and informs diagnostic decisions, particularly in distinguishing between AD and non-AD diagnoses.
Authors
- Kristin Harkins (ORCID: https://orcid.org/0000-0001-5360-1043)
- Cameron Coykendall (ORCID: https://orcid.org/0000-0002-4983-401X)
- Abigail Perelman
- Megan Zhang
- Kyra O’Brien
- Jason Karlawish
Institutions
- University of Pennsylvania (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101304
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00